The nicotinic acetylcholine receptor agonist (±)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain

Molecular Brain Research

Volumn 74, Issue 1-2, 1999, Pages 98-110

  Belluardo, Natale ^a   Mudò, Giuseppa ^b,c   Blum, Mariann ^d   Cheng, Qingzhang ^c   Caniglia, Giuseppa ^c   Dell'Albani, Paola ^c   Fuxe, Kjell ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CATANIA   (Italy)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

( ) Epibatidine; Brain derived neurotrophic factor; Fibroblast growth factor receptor 1; Fibroblast growth factor 2; Glial cell line derived neurotrophic factor; Nicotinic acetylcholine receptor agonist

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; EPIBATIDINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MECAMYLAMINE; MESSENGER RNA; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ARTICLE; BRAIN; BRAIN REGION; CEREBELLUM CORTEX; CORPUS STRIATUM; DOSE RESPONSE; GENE EXPRESSION; HYPOTHALAMUS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MESENCEPHALON; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TELENCEPHALON;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MECAMYLAMINE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; TIME FACTORS;

EID: 0033402934     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00266-1     Document Type: Article

References (78)

1. Akaike A., Tamura Y., Yokota T., Shimohama S., Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644:1994;181-187.
2. 3H ]ABT-418: a novel cholinergic channel ligand J. Pharmacol. Exp. Ther. 273:1995;1434-1441.
3. Anderson K.J., Dam D., Lee S., Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 332:1988;360-361.
4. Badio B., Daly J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 45:1994;563-569.
5. Baird A. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr. Opin. Neurobiol. 4:1994;78-86.
6. Ballarin M., Ernfors P., Lindefors N., Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp. Neurol. 114:1991;35-43.
7. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
8. Baron J.A. Cigarette smoking and Parkinson's disease. Neurology. 36:1986;1490-1496.
9. Belluardo N., Blum M., Mudo G., Andbjer B., Fuxe K. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat. Neuroscience. 83:1998;723-740.
10. Belluardo N., Wu G., Mudo G., Hansson A.C., Pettersson R., Fuxe K. Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysis. J. Comp. Neurol. 379:1997;226-246.
11. Bencherif M., Schmitt J.D., Bhatti B.S., Crooks P., Caldwell W.S., Lovette M.E., Fowler K., Reeves L., Lippiello P.M. The heterocyclic substituted pyridine derivative (±)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 284:1998;886-894.
12. Benfenati F., Cimino M., Agnati L.F., Fuxe K. Quantitative autoradiography of central neurotransmitter receptors: methodological and statistical aspects with special reference to computer-assisted image analysis. Acta Physiol. Scand. 128:1986;129-146.
13. Blum M. Regulation of neuroendocrine peptide gene expression. Methods Enzymol. 168:1989;618-633.
14. Bugler B., Amalric F., Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell Biol. 11:1991;573-577.
15. Chadi G., Moller A., Rosen L., Janson A.M., Agnati L.A., Goldstein M., Ögren S.O., Pettersson R.F., Fuxe K. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp. Brain Res. 97:1993;145-158.
16. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
17. 125I ]-alpha-bungarotoxin J. Neurosci. 5:1985;1307-1315.
18. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27:1998;1-39.
19. da Penha Berzaghi M., Cooper J., Castren E., Zafra F., Sofroniew M., Thoenen H., Lindholm D. Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J. Neurosci. 13:1993;3818-3826.
20. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56:1995;545-570.
21. Decker M.W., Brioni J.D., Sullivan J.P., Buckley M.J., Radek R.J., Raszkiewicz J.L., Kang C.H., Kim D.J., Giardina W.J., Wasicak J.T.et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. J. Pharmacol. Exp. Ther. 270:1994;319-328.
22. Dell'Albani P., Kahn M.A., Cole R., Condorelli D.F., Giuffrida-Stella A.M., de Vellis J. Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways. J. Neurosci. Res. 54:1998;191-205.
23. Emoto N., Gonzalez A.M., Walicke P.A., Wada E., Simmons D.M., Shimasaki S., Baird A. Basic fibroblast growth factor (FGF) in the central nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors. 2:1989;21-29.
24. Ferrari G., Minozzi M.C., Toffano G., Leon A., Skaper S.D. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133:1989;140-147.
25. Finklestein S.P., Apostolides P.J., Caday C.G., Prosser J., Philips M.F., Klagsbrun M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 460:1988;253-259.
26. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41:1992;31-37.
27. Florkiewicz R.Z., Baird A., Gonzalez A.M. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors. 4:1991;265-275.
28. Florkiewicz R.Z., Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. USA. 86:1989;3978-3981.
29. Freese A., Finklestein S.P., DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 575:1992;351-355.
30. Fuxe K., Janson A.M., Jansson A., Andersson K., Eneroth P., Agnati L.F. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;171-181.
31. Gall C.M., Berschauer R., Isackson P.J. Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia. Mol. Brain Res. 21:1994;190-205.
32. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
33. Giordano S., Sherman L., Lyman W., Morrison R. Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the central nervous system. Dev. Biol. 152:1992;293-303.
34. Gonzalez A.M., Berry M., Maher P.A., Logan A., Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 701:1995;201-206.
35. Grandinetti A., Morens D.M., Reed D., MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am. J. Epidemiol. 139:1994;1129-1138.
36. 3H ]nicotine Acta Physiol. Scand. 132:1988;1-14.
37. 3H ]epibatidine binding to nicotinic cholinergic receptors in rat and human brain Mol. Pharmacol. 48:1995;280-287.
38. Huber K., Meisinger C., Grothe C. Expression of fibroblast growth factor-2 in hypoglossal motoneurons is stimulated by peripheral nerve injury. J. Comp. Neurol. 382:1997;189-198.
39. Janson A.M., Fuxe K., Agnati L.F., Kitayama I., Harfstrand A., Andersson K., Goldstein M. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res. 455:1988;332-345.
40. Janson A.M., Fuxe K., Goldstein M. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse. Clin. Invest. 70:1992;232-238.
41. Janson A.M., Fuxe K., Sundstrom E., Agnati L.F., Goldstein M. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta Physiol. Scand. 132:1988;589-591.
42. Janson A.M., Moller A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience. 57:1993;931-941.
43. Kamiguchi H., Yoshida K., Wakamoto H., Inaba M., Sasaki H., Otani M., Toya S. Cytokine-induced selective increase of high-molecular-weight bFGF isoforms and their subcellular kinetics in cultured rat hippocampal astrocytes. Neurochem. Res. 21:1996;701-706.
44. Kiyota Y., Takami K., Iwane M., Shino A., Miyamoto M., Tsukuda R., Nagaoka A. Increase in basic fibroblast growth factor-like immunoreactivity in rat brain after forebrain ischemia. Brain Res. 545:1991;322-328.
45. Knusel B., Michel P.P., Schwaber J.S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10:1990;558-570.
46. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology (Berlin). 108:1992;417-431.
47. Lippoldt A., Andbjer B., Rosen L., Richter E., Ganten D., Cao Y., Pettersson R.F., Fuxe K. Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA. Brain Res. 625:1993;45-56.
48. Lloyd G.K., Menzaghi F., Bontempi B., Suto C., Siegel R., Akong M., Stauderman K., Velicelebi G., Johnson E., Harpold M.M., Rao T.S., Sacaan A.I., Chavez-Noriega L.E., Washburn M.S., Vernier J.M., Cosford N.D., McDonald L.A. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci. 62:1998;1601-1606.
49. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193:1951;265-275.
50. Mattson M.P., Murrain M., Guthrie P.B., Kater S.B. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9:1989;3728-3740.
51. Menzaghi F., Whelan K.T., Risbrough V.B., Rao T.S., Lloyd G.K. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. J. Pharmacol. Exp. Ther. 280:1997;384-392.
52. Morrison R.S., Sharma A., de Vellis J., Bradshaw R.A. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA. 83:1986;7537-7541.
53. Mudo G., Jiang X.H., Timmusk T., Bindoni M., Belluardo N. Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine. Epilepsia. 37:1996;198-207.
54. Nakata N., Kato H., Kogure K. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 605:1993;354-356.
55. Otto D., Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10:1990;1912-1921.
56. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
57. 3H ]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study J. Pharmacol. Exp. Ther. 275:1995;1030-1034.
58. Prats H., Kaghad M., Prats A.C., Klagsbrun M., Lelias J.M., Liauzun P., Chalon P., Tauber J.P., Amalric F., Smith J.A.et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. USA. 86:1989;1836-1840.
59. Qian C., Li T., Shen T.Y., Libertine-Garahan L., Eckman J., Biftu T., Ip S. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:1993;R13-14.
60. Renko M., Quarto N., Morimoto T., Rifkin D.B. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell Physiol. 144:1990;108-114.
61. Riva M.A., Gale K., Mocchetti I. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Brain Res. Mol. Brain Res. 15:1992;311-318.
62. Sacaan A.I., Reid R.T., Santori E.M., Adams P., Correa L.D., Mahaffy L.S., Bleicher L., Cosford N.D., Stauderman K.A., McDonald I.A., Rao T.S., Lloyd G.K. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J. Pharmacol. Exp. Ther. 280:1997;373-383.
63. Safran A., Avivi A., Orr U.A., Neufeld G., Lonai P., Givol D., Yarden Y. The murine flg gene encodes a receptor for fibroblast growth factor. Oncogene. 5:1990;635-643.
64. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
65. Schmidt-Kastner R., Tomac A., Hoffer B., Bektesh S., Rosenzweig B., Olson L. Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Brain Res. Mol. Brain Res. 26:1994;325-330.
66. 125I -neuronal bungarotoxin J. Neurosci. 11:1991;287-297.
67. Shimasaki S., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A., Ling N. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem. Biophys. Res. Commun. 157:1988;256-263.
68. Spande T.F., Garaffo H.M., Edwards M.W., Yeh H.J.C., Pannel L., Daly J.W. Epibatidine: a novel (cloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuatorian poison frog. J. Am. Chem. Soc. 114:1992;3475-3480.
69. Stachowiak M.K., Moffett J., Maher P., Tucholski J., Stachowiak E.K. Growth factor regulation of cell growth and proliferation in the nervous system. A new intracrine nuclear mechanism. Mol. Neurobiol. 15:1997;257-283.
70. Sullivan J.P., Decker M.W., Brioni J.D., Donnelly-Roberts D., Anderson D.J., Bannon A.W., Kang C.H., Adams P., Piattoni-Kaplan M., Buckley M.J.et al. (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271:1994;624-631.
71. Takami K., Iwane M., Kiyota Y., Miyamoto M., Tsukuda R., Shiosaka S. Increase of basic fibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia. Exp. Brain Res. 90:1992;1-10.
72. Timmusk T., Belluardo N., Metsis M., Persson H. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur. J. Neurosci. 5:1993;605-613.
73. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17:1997;3554-3567.
74. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
75. Walicke P., Cowan W.M., Ueno N., Baird A., Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. USA. 83:1986;3012-3016.
76. Walicke P.A. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8:1988;2618-2627.
77. Wanaka A., Johnson E.J., Milbrandt J. Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron. 5:1990;267-281.
78. Wetmore C., Ernfors P., Persson H., Olson L. Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp. Neurol. 109:1990;141-152.